ARCHITECT ANTI-HBS
Report
- Report Number
- 1415939-2008-00071
- Event Type
- Other
- Date Received
- May 22, 2008
- Date of Event
- May 6, 2008
- Report Date
- May 16, 2008
- Manufacturer
- ABBOTT LABORATORIES
- Product Code
- LOM
- PMA / PMN Number
- P050051
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TU
- Reporter Occupation
- OTHER
Narratives
INVESTIGATION IN PROCESS, NO CONCLUSION CAN BE DRAWN. THE BASIS FOR THIS REPORT IS THAT THERE IS A SIMILAR PRODUCT MARKETED IN THE UNITED STATES (US). THE US PRODUCT LIST NUMBER IS 1L82 AND IS MARKETED AS ARCHITECT AUSAB. THIS PRODUCT MEETS THE CRITERIA FOR A 5-DAY MDR AS DESCRIBED IN THE FDA'S NOTICE DATED APRIL 8, 2008 [TO MANUFACTURERS AND INITIAL DISTRIBUTORS OF MEDICAL DEVICES THAT MAY CONTAIN HEPARIN OR ARE HEPARIN-COATED], AND ABBOTT IS SUBMITTING THIS 5-DAY MDR. OUR INVESTIGATION INTO THIS EVENT IS ONGOING AND A SUPPLEMENTAL MDR WILL BE SUBMITTED AT THE CONCLUSION OF OUR INVESTIGATION.
THE ACCOUNT STATED, THE ARCHITECT ANTI-HBS ASSAY IS GENERATING UNEXPECTED REACTIVE RESULTS. THE SAME ARCHITECT ANTI-HBS SPECIMENS TEST AXSYM AUSAB NEGATIVE. THE ARCHITECT ANTI-HBS CONTROLS ARE IN RANGE. THE ACCOUNT USED SERUM SAMPLES FOR TESTING. THE REACTIVE ARCHITECT ANTI-HBS RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. NO IMPACT TO PT MANAGEMENT WAS REPORTED. HBSAG = 14.65 (NO UNITS OF MEASURE GIVEN, METHOD UNK). ARCHITECT ANTI-HBS = 24.02 MIU/ML REACTIVE. AXSYM AUSAB = 0.4 MIU/ML NEGATIVE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ARCHITECT ANTI-HBS | CMIA FOR THE QUANTITATIVE DETERMINATION OF ANTIBODY TO HEPATITIS B SURFACE ANTIG | LOM | ABBOTT LABORATORIES | NA | 51297M100 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK | ARCHITECT ANALYZER, LIST 3M74-01 |